ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
MVASI, KANJINTI Now Available in United States
July 22, 2019Amgen and Allergan announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab), are now available in the United States. -
FDA Approves KANJINTI
June 20, 2019Amgen and Allergan announced the U.S. Food and Drug Administration (FDA) has approved KANJINTI™ (trastuzumab-anns) for all approved indications of the reference product ... -
FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin
June 17, 2019FDA Approves Kanjinti.
Pharma Sources Insight January 2025
